Iterum Therapeutics plc Ordinary Share (ITRM) Dividend History

Iterum Therapeutics plc is a clinical-stage pharmaceutical company focused on developing and commercializing innovative antibiotics for serious and life-threatening infections. The company aims to address the growing problem of antibiotic resistance by creating new therapies to treat resistant bacterial infections. Its pipeline includes oral and intravenous formulations designed to combat multidrug-resistant pathogens.

Fitzwilliam Court, 1st Floor, Dublin 2, L2, D02 YW24
Phone: (872) 225-6077
Website: https://www.iterumtx.com

Dividend History

Iterum Therapeutics plc Ordinary Share currently does not pay dividends

Company News

  • Iterum Therapeutics Announces Partnership for Commercialization Services

    Iterum Therapeutics announced a partnership with EVERSANA to commercialize its approved product ORLYNVAHTM, an oral penem antibiotic for the treatment of uncomplicated urinary tract infections, in the U.S. by Q4 2025.

    GlobeNewswire Inc.
  • Iterum (ITRM) Plans Early Submission of UTI Drug NDA, Stock Up

    Iterum (ITRM) stock rises as the company gears up to submit a regulatory application to the FDA seeking approval for oral sulopenem to treat adult women with uUTIs ahead of schedule.

    Zacks Investment Research
    Featured Companies: ACET ADMA FGEN
  • Insiders Buying Iterum Therapeutics And 3 Other Stocks Under $3

    The Dow Jones index closed higher by over 100 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Iterum Therapeutics The Trade: Iterum Therapeutics plc (NASDAQ: ITRM) Director Michael W Dunne acquired a total of 25,000 shares an average price of $1.40. To acquire these shares, it cost around $35,000. What’s Happening: Iterum Therapeutics recently regained compliance with Nasdaq Bid Price Rule for continued listing. What Iterum ...

    Benzinga
    Featured Companies: NTWK RVP
  • Penny Stocks To Buy Now? 7 Hot Stocks Under $1 To Watch

    More penny stocks to watch under $1 The post Penny Stocks To Buy Now? 7 Hot Stocks Under $1 To Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
  • Why Iterum Therapeutics Stock Is Crashing Today

    The company received disappointing news from the FDA.

    The Motley Fool
Page data last updated 07/25/2025 01:27:06 UTC